美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Evolution Health Group might have fallen short on meeting 2023’s revenue growth target of 30%, but a nearly 20% increase amid a chaotic economic environment is certainly not the worst consolation prize. When the year’s results were tallied, the agency saw revenue rise just north of 18%, to $38.5 million from $32.6 million in 2022.

      Some of the growth came from expanded relationships with existing members of Evolution’s client roster, which includes Takeda (14 different assignments), Janssen (seven) and Sun Pharma (six). The agency also scored its share of new business, claiming engagements with Johnson & Johnson (multiple myeloma franchise), Regeneron (on non-small cell lung cancer drug Libtayo), Scholar Rock (on promising spinal muscular atrophy treatment apite-
      gromab) and Verastem Oncology.

      Evolution’s relationship with Corium ended when the company ceased promotion of its Alzheimer’s dementia treatment Adlarity.

      Managing partner Carolyn Vogelesang Harts believes that Evolution’s strategic thinking is often what appeals most to prospective clients. At the same time, she notes that as much as these organizations may want to avail themselves of such services, they’re more constrained than ever before by their marketing budgets. Too often, she adds, such pressures result in companies choosing a tried-and-true solution rather than experimenting with innovative ideas.

      Amid this client environment, Evolution figured out how to do more with less. It ended 2023 with 108 full-timers under its roof, 20 fewer people than it had on hand at the start of the year. Harts explains the seeming discrepancy — historically, few agencies have been able to drive up revenue while cutting back on staff — by pointing to a pair of factors.

      Evolution Health Group creative sample

      “We have been streamlining our team, which has been made possible due to our continued investment in our technology platforms,” she notes. “In addition, the nature of the work impacts the resources that we have on board. In 2023, there was a shift to more strategic work requiring less manpower.”

      Managing partner Andrea Lanzetta agrees, reporting that Evolution’s embrace of next-gen technology has contributed to its client-development successes. Lanzetta and Harts, along with fellow managing partner Mark Edfort, are particularly bullish on the organization’s soon-to-launch speaker bureau system. Edfort, in fact, believes the new system is poised to become the health and wellness industry’s leading speaker bureau management platform.

      “Most speaker bureau platforms today are based on legacy software, not on the ability to integrate new tools,” he explains. “Ours is going to be just that.” Another recent addition to the agency’s technology toolkit includes a social listening platform.

      Looking forward, Edfort, Harts and Lanzetta believe that a pair of 2023 staff arrivals will help the agency realize its growth ambitions in the rest of 2024 and beyond. Todd Courcy, who previously served in the corporate strategy office of Envision Pharma Group, joined Evolution in June 2023 as EVP, client integration. Ram Sarma, formerly director, digital experience platforms and alliances at Protiviti, joined the company in October as VP, technology and software development, Blulava. 

      . . .

      Work we wish we did

      Taylor Swift is a true marketing genius. She and her team have created and maintained one of the greatest brands in the entertainment industry. With The Eras Tour, Swift took a traditional tour and turned it into a movie, which speaks to her creativity and passion for producing the extraordinary. — Edfort

      Click to see Evolution Health Group’s Agency 100 2023 Profile.

      Click here to return to the MM+M Agency 100.